1-4 of 4
Jing Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Morin Inhibits Proliferation and Induces Apoptosis by Modulating the miR-188-5p/PTEN/AKT Regulatory Pathway in CML Cells

Free
Zi-Yuan Nie, Lin Yang, Xiao-Jun Liu, Zhan Yang, Gao-Shan Yang, Jing Zhou, Yan Qin, Jing Yu, Ling-Ling Jiang, Jin-Kun Wen, Jian-Min Luo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12): 2296–2307.
https://doi.org/10.1158/1535-7163.MCT-19-0051
Published: 02 December 2019
View articletitled, Morin Inhibits Proliferation and Induces Apoptosis by Modulating the miR-188-5p/PTEN/AKT Regulatory Pathway in CML Cells
Open the PDF for Morin Inhibits Proliferation and Induces Apoptosis by Modulating the miR-188-5p/PTEN/AKT Regulatory Pathway in CML Cells in another window
Includes: Supplementary data
Journal Articles

Abstract B013: Elevation of immune cell infiltration and interferon-stimulated gene expression is associated with niraparib treatment in murine syngeneic tumor models

Free
Sarah Wang, Kaiming Sun, Yonghong Xiao, Keith Mikule, Sridhar Ramaswamy, Jeffrey Hanke, Jing Yu Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): B013.
https://doi.org/10.1158/1535-7163.TARG-17-B013
Published: 01 January 2018
View articletitled, Abstract B013: Elevation of immune cell infiltration and interferon-stimulated gene expression is associated with niraparib treatment in murine syngeneic tumor models
Journal Articles

Abstract A102: A comparative pharmacokinetic-pharmacodynamic-treatment study of PARP inhibitors demonstrates favorable properties for niraparib activity in preclinical tumor models

Free
Kaiming Sun, Grace Poon, Sarah Wang, Paul Vancutsem, Sridhar Ramaswamy, Jeffrey Hanke, Jing Yu Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A102.
https://doi.org/10.1158/1535-7163.TARG-17-A102
Published: 01 January 2018
View articletitled, Abstract A102: A comparative pharmacokinetic-pharmacodynamic-treatment study of PARP inhibitors demonstrates favorable properties for niraparib activity in preclinical tumor models
Journal Articles

CVX-045: A novel antiangiogenic CovX-Body™ that potentiates targeted therapy in preclinical colon cancer models.

Free
Steven Pirie-Shepherd, Tom Leedom, Lingna Li, Kimberly Johnson, Janet Do, Hanhua Huang, Trina Osothprarop, Joselyn Del Rosario, Kimberly Broadwell, Kristen Bower, Jing-Yu Lai, John Rizzo, Venkata Doppalapudi, Rodney Lappe, Curt Bradshaw, Stanley Roberts, Nancy Levin, Gary Woodnutt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A18.
Published: 01 November 2007
View articletitled, CVX-045: A novel antiangiogenic CovX-Body™ that potentiates targeted therapy in preclinical colon cancer models.